Purple Biotech annual depreciation and amortization
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Purple Biotech Depreciation & Amortization Growth & History (PPBT)
Purple Biotech's depreciation and amortization was $203,000 for fiscal 2025.
View full Purple Biotech company overviewPurple Biotech annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $203,000 | $17,000 | +9.14% |
| 2024 | 2024-12-31 | $186,000 | −$13,000 | −6.53% |
| 2023 | 2023-12-31 | $199,000 | −$2,000 | −1.00% |
| 2022 | 2022-12-31 | $201,000 | −$30,000 | −12.99% |
| 2021 | 2021-12-31 | $231,000 | −$4,000 | −1.70% |
| 2020 | 2020-12-31 | $235,000 | $57,000 | +32.02% |
| 2019 | 2019-12-31 | $178,000 | $171,000 | +2442.86% |
| 2018 | 2018-12-31 | $7,000 | $3,000 | +75.00% |
| 2017 | 2017-12-31 | $4,000 | $2,000 | +100.00% |
| 2016 | 2016-12-31 | $2,000 | $1,000 | +100.00% |
| 2015 | 2015-12-31 | $1,000 | — | — |
Purple Biotech quarterly depreciation and amortization
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $70,000 | $23,000 | +48.94% |
| Q1 2026 | 2026-03-31 | $65,000 | — | — |
| Q4 2025 | 2025-12-31 | $53,000 | — | — |
| Q3 2025 | 2025-09-30 | $58,000 | — | — |
| Q2 2025 | 2025-06-30 | $47,000 | — | — |
Purple Biotech depreciation and amortization trends
Over the last five fiscal years, Purple Biotech's depreciation and amortization decreased from $235,000 to $203,000, a change of −$32,000. The latest reported quarter, Q2 2026, shows $70,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Purple Biotech source filings ↗